HA Filler Brands Available in Korea
Korea’s aesthetic medicine market is one of the most competitive globally, which keeps filler pricing below Western benchmarks and product availability high. Both international brands and domestically manufactured fillers are in wide clinical use.
All filler products sold in Korea require approval from the MFDS (Ministry of Food and Drug Safety — Korea’s equivalent of the US FDA or Australia’s TGA). Juvederm and Restylane hold full MFDS approval and are stocked at most Gangnam-district aesthetic clinics. Korean-brand fillers, principally Yvoire and Elravie, carry the same regulatory status and are used routinely in Korean domestic practice.
| Product | Primary use | Typical KRW cost | USD equivalent | AUD equivalent | Notes |
|---|---|---|---|---|---|
| Juvederm Ultra | Lips, fine lines, mid-face | ₩350,000–500,000 | USD$260–370 | AUD$370–530 | Allergan/AbbVie; most requested by international patients |
| Juvederm Voluma | Cheek and mid-face volumisation | ₩450,000–600,000 | USD$330–440 | AUD$480–640 | Longer duration (up to 18–24 months); higher G-prime (firmness) |
| Restylane | Lips, perioral lines, under-eye | ₩300,000–480,000 | USD$220–350 | AUD$320–510 | Galderma; NASHA technology; widely available |
| Restylane Lyft | Cheeks, nasolabial folds, hands | ₩400,000–560,000 | USD$295–410 | AUD$425–595 | Larger particle size than standard Restylane |
| Yvoire (Korean) | Lips, folds, nose bridge | ₩200,000–350,000 | USD$150–260 | AUD$215–370 | LG Chem; MFDS-approved; 30–50% lower cost than Juvederm |
| Elravie (Korean) | Mid-face, folds, contouring | ₩200,000–340,000 | USD$150–250 | AUD$215–360 | Huons; MFDS-approved; used widely in Korean domestic clinics |
Clinic consultations are typically free or low-cost (₩0–50,000) in Seoul’s Gangnam district, where competition is densest. Injector seniority and clinic tier affect pricing — a board-certified plastic surgeon injector will generally charge more than a nurse injector at a chain aesthetic clinic.¹
Korean Filler Technique: What’s Different
The most consistent difference between Korean and Western filler aesthetics is the preference for structural subtlety. Korean injectors are trained within an aesthetic framework that values 자연스러움 (jayeonseureowm — naturalness) as the primary outcome measure. This shows up in several concrete technical choices.
Volume per session is lower. A Korean injector treating lips will often use 0.5–0.8 ml total where a Western injector might use 1.0–2.0 ml. The goal is definition and hydration rather than visible volume increase. Patients accustomed to Western filler volumes should state their preferred outcome explicitly at consultation — do not assume the injector will match what you are used to.
Nose bridge (코 필러, ko pilleo — nose filler) is a distinct Korean specialty. Non-surgical nose augmentation using HA filler injected along the dorsum (bridge) to raise height and refine the tip is far more common in Korea than in Western practice. Korean injectors have higher case volumes in this area, but it carries meaningful vascular risk at any skill level — the nose has terminal blood vessels and filler-related vascular occlusion is a serious complication. This risk exists regardless of injector nationality or experience.
Cannula use is widespread. Many Korean clinics use blunt-tip cannulas rather than sharp needles for cheek and under-eye placement, which reduces bruising and the risk of intravascular injection in those areas. Cannulas do not eliminate vascular risk at the nose.
Layered mid-face architecture. Korean technique for cheek and temple volume tends to address multiple tissue planes — periosteal (bone-adjacent), sub-SMAS (beneath the facial muscle layer), and superficial — in a single session, rather than purely superficial injection. This produces a more three-dimensional and longer-lasting result but requires detailed anatomical knowledge.¹
Filler vs Surgery for Nose and Face
The decision between HA filler and surgery is a question of permanence, magnitude of change, and reversibility — not simply cost.
Filler advantages: HA filler is reversible — hyaluronidase (an enzyme injection) dissolves it within 24–48 hours if the result is unsatisfactory or a complication occurs. Downtime is minimal (24–72 hours of minor swelling and bruising). For patients wanting to trial a change before committing to surgery, filler is a legitimate diagnostic tool.
Filler limits: HA filler lasts 9–18 months depending on product, area, and individual metabolism. Structural changes — reducing a dorsal hump (bony bump on the nose bridge), correcting a deviated septum, narrowing a wide nasal base — cannot be achieved with filler. Filler adds volume; it does not remove or reposition tissue.
Where filler and surgery address different problems: A patient with a low, flat nose bridge wanting more height can achieve a temporary result with filler (₩200,000–500,000, USD$150–370, AUD$215–530) or a permanent structural result with rhinoplasty (₩3.5–8M, USD$2,600–5,900, AUD$3,700–8,500). These are not equivalent options — one is a temporary augmentation, the other is a structural reconstruction.
The combination approach: Some patients use filler to trial a nose shape change, then proceed to rhinoplasty if satisfied with the direction. Korean surgeons generally have no objection to this sequence, provided the filler has been dissolved or has fully metabolised before surgery. Residual filler at the surgical site complicates tissue dissection.¹
Adding Filler to a Surgery Trip: Timing Rules
Three timing windows apply when combining filler with a surgical procedure in Seoul.
Before surgery (7+ days prior): HA filler to non-operative areas — lips, cheeks, temples — carries low interaction risk if placed at least one week before surgery. Filler placed closer than 7 days to surgery may contribute to facial swelling that is difficult to distinguish from surgical swelling in the early recovery period.
Immediately after surgery (days 0–14): Filler in any facial area is inadvisable during this window. Surgical swelling distorts facial anatomy, making accurate filler placement unreliable. A volume that looks correct over post-surgical swelling will appear excessive once swelling resolves. Most Korean clinics will decline to inject filler in this period.
At the 6-week post-op visit: Swelling from most facial surgeries (rhinoplasty, double eyelid surgery — 쌍꺼풀, ssangkkeopul) has largely resolved by week 6. This is the earliest appropriate window for adding filler to a surgically treated area or adjacent zones. If you have left Korea before week 6, this appointment can be completed with a qualified injector in your home country.
Practical note for surgical tourists: If your Seoul trip is 10–14 days, the viable filler window is either the pre-surgery consultation appointment (7+ days before the procedure) or a follow-up trip. Plan accordingly rather than assuming filler can be added ad hoc during recovery.¹
Is filler cheaper in Korea than in the UK or Australia?
Yes, meaningfully so. A Juvederm syringe in Korea costs approximately USD$200–350; the same product in the UK runs £350–500 and in Australia AU$700–1,000. The cost difference is significant enough that adding 1–2 syringes to a surgical trip produces measurable savings, though filler alone wouldn't justify the trip cost. If you're already in Seoul for surgery, scheduling filler at a pre- or post-surgery appointment makes financial sense.
Can I get lip filler in Korea on the same trip as rhinoplasty?
Yes, but timing matters. Lip filler placed before rhinoplasty (7+ days prior) is generally low-risk. Lip filler placed immediately after rhinoplasty is inadvisable — your face will have surgical swelling, making accurate filler placement difficult and the result unreliable. Most Korean clinics recommend waiting until the 6-week post-op visit (either in Seoul if you return, or with a home-country injector) before adding filler around an operated area. Your surgeon will give specific guidance based on your procedure.
Are Korean filler brands like Yvoire as good as Juvederm?
Korean HA filler brands (Yvoire by LG Chem, Elravie by Huons) are MFDS-approved (Korea's FDA equivalent) and are used widely in Korean aesthetic medicine. They are typically priced 30–50% lower than Juvederm or Restylane. Clinical studies on Korean domestic brands are less extensive than on Juvederm (which has decades of global data), but they use similar HA cross-linking technology. Most international patients travelling to Korea for filler request Juvederm or Restylane specifically for the track record — both are readily available.
¹ Korean Society of Plastic and Reconstructive Surgeons — Board Certification Registry. plasticsurgery.or.kr. Accessed 2026-07-28.